Flu Shots and Ischemic Stroke Risk in Older Adults
Drug Topics
NOVEMBER 2, 2022
Recently published research reveals an important benefit for middle-aged and older adults: a reduction in ischemic stroke risk.
Wed.Nov 02, 2022
503 
Woman of the Week: City of Hope’s Gulden Mesara
PharmaVoice
NOVEMBER 2, 2022
Charged with bridging the 100-year-old research center to its future mission of holistic patient cancer care, Mesara is bringing decades of experience in communications and culture creation.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Crisis (Not) Averted
Drug Topics
NOVEMBER 2, 2022
It’s too late for retail chain pharmacies to engage in the preventive maintenance that would have spared them the worst of the Great Resignation.
How Europe’s energy crisis is impacting pharma
PharmaVoice
NOVEMBER 2, 2022
Inflationary pressures and rising energy costs could further expedite the movement of generics manufacturing from Europe to Asia if governments don’t step in.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
FDA Approves Olipudase Alfa-rpcp for Acid Sphingomyelinase Deficiency
Drug Topics
NOVEMBER 2, 2022
Acid sphingomyelinase deficiency is a rare, progressive genetic disease associated with significant morbidity and mortality.
Evolution of Pharmacist Role in Treatment and Management of Breast Cancer
Pharmacy Times
NOVEMBER 2, 2022
Dr Vinokurov illustrates the evolving role of pharmacists in HR+/HER2- breast cancer treatment.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Factors Guiding Treatment of HR+/HER2- Breast Cancer
Pharmacy Times
NOVEMBER 2, 2022
Wassim McHayleh, MD, MBA, FACP, and Alisa Vinokurov, PharmD, discuss HR+/HER2- breast cancer.
“Universal” CRISPR-edited T cells improve resistant leukaemia
European Pharmaceutical Review
NOVEMBER 2, 2022
Researchers at Great Ormond Street Hospital for Children (GOSH) and University College London (UCL) Great Ormond Street Institute of Child Health (UCL GOS ICH) have used “universal” CRISPR-edited cells in humans for the first time to treat B-cell acute lymphoblastic leukaemia (B-ALL) child patients with engineered donor T cells. The treatment did not require matching donor cells, a major step in developing gene-edited cells for cancer treatment.
Finerenone May Protect Patients With Chronic Kidney Disease From Pneumonia-Related Severe Adverse Events
Pharmacy Times
NOVEMBER 2, 2022
The drug is a selective, nonsteroidal mineralocorticoid receptor antagonist found to also protect against COVID-19 and pneumonia-related adverse events in patients with diabetes.
STAT+: A turnaround for Editas Medicine, a CRISPR laggard, hinges on updates on key treatments
STAT
NOVEMBER 2, 2022
Editas Medicine’s new leadership team on Wednesday reiterated a promise to deliver clinical updates on two CRISPR-based treatments before the end of the year — data the troubled biotech hopes will ease investor doubts about its gene-editing technology. Other CRISPR companies command multibillion-dollar valuations, but Editas, one of the originals, trades below its IPO price after years of management upheaval and clinical delay.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Respiratory Syncytial Virus Vaccine Candidate Found to Protect Infants Against Severe Illness
Pharmacy Times
NOVEMBER 2, 2022
Pre-planned safety reviews performed for the duration of the study found that the investigational vaccine is well-tolerated with no safety concerns for both the vaccinated individuals and their newborns.
CVS Health to sell Omnicare
Drug Store News
NOVEMBER 2, 2022
In an SEC filing on Wednesday CVS said that it is “determined that its LTC business was no longer a strategic asset, and during the third quarter of 2022 committed to a plan to sell.
Tip of the Week: Adult Learning is a Wise Investment for Onboarding New Employees
Pharmacy Times
NOVEMBER 2, 2022
Investing in adequate education and training of new employees up front can save a considerable amount of time and money on the back end.
Pfizer records 6% decline in revenue in Q3 2022
Pharmaceutical Technology
NOVEMBER 2, 2022
Pfizer has reported a 6% decline in revenue to $22.6bn in the third quarter (Q3) of 2022 as against $24bn in the same quarter last year. In the quarter, revenues rose 2% operationally on omitting contributions from Covid-19 therapies, Paxlovid and Comirnaty. Reduction in revenues from Comirnaty outside the US and reduced revenues for some Comirnaty-linked manufacturing works carried out on behalf of BioNTech, Xeljanz and Sutent worldwide were the key drivers that contributed to the revenue dec
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
FDA Approves Tenofovir Alafenamide for Chronic Hepatitis B Virus in Pediatric Patients
Pharmacy Times
NOVEMBER 2, 2022
Tenofovir alafenamide is a nucleoside analog reverse transcriptase inhibitor specifically indicated to treat HBV in adults with compensated liver disease.
Opinion: Give Americans the right to save on health care
STAT
NOVEMBER 2, 2022
Dani Yuengling, a 35-year-old South Carolinian, had a family history of fatal breast cancer. So when she noticed a lump in one of her breasts, she immediately made an appointment to see her doctor. Though her biopsy was covered by insurance, she still had to pay $5,169 out of her own pocket. If she hadn’t used her insurance, Yuengling would have saved $3,000.
Initiation of Antiretroviral Therapy Reduces Number of Active HIV-Infected Cells
Pharmacy Times
NOVEMBER 2, 2022
ART also results in a faster decay of plasma HIV RNA and increased HIV CD8+T cell immunity compared with the treatment alone, investigators found.
Which industry has the most job quitters?
Drug Store News
NOVEMBER 2, 2022
New research has revealed which industries are losing the most employees.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Physicians rally to avert Medicare payment cuts
STAT
NOVEMBER 2, 2022
The federal government is officially reducing Medicare payments to physicians next year by 4.5%, but doctors and their lobbyists are ready to blitz Congress over the next two months to convince lawmakers that those cuts should be averted — again. Medicare signaled these cuts were coming over the summer and finalized them this week in a new regulation.
Lilly says Mounjaro launch is “viral in nature”
pharmaphorum
NOVEMBER 2, 2022
One of the highlights of Eli Lilly’s third-quarter results was the rapid uptake of new type 2 diabetes therapy Mounjaro, which added more than $97 million in US sales alone in what has been described as “viral” take-up by the drugmaker. Lilly’s head of diabetes, Mike Mason, said on the company’s results call that the rollout of Mounjaro (tirzepatide) was “really unprecedented” for a new diabetes therapy in the US, and had been driven by “tremendous
STAT+: Weight-loss drug had dramatic effect in adolescents with obesity, study finds
STAT
NOVEMBER 2, 2022
A blockbuster weight-loss medicine led to dramatic effects for adolescents diagnosed with obesity, a result that will likely widen the use of an in-demand drug — and fan a debate over whether someone’s body weight should be treated as a disease. The drug, a weekly injection called semaglutide, led to a 17% reduction in body mass index compared to placebo in a study of about 200 people between the ages of 12 and 18.
Norstella, Citeline merge to create $5bn pharma tech firm
pharmaphorum
NOVEMBER 2, 2022
Citeline and Norstella have completed a merger, first announced in June, to create one of the largest players in the pharmaceutical intelligence category. Citeline provides intelligence, data and software for clinical trials, development and regulatory compliance and was formerly part of Informa was called Pharma Intelligence ahead of a rebranding earlier this year.
‘Intriguing and sobering’: Enthusiasm over psilocybin’s effect on depression tempered by questions about durability
STAT
NOVEMBER 2, 2022
The hype around psychedelic therapy has been put to the test, with the publication Wednesday of the largest-ever study of psilocybin to treat depression. The Phase 2 trial found that the drug was effective — it reduced or eliminated symptoms in the short term in more than one-third of patients who took the highest dose — but not as dazzlingly powerful as earlier smaller studies had suggested.
Kiss Lashes marks 1st influencer collaboration with Meredith Duxbury
Drug Store News
NOVEMBER 2, 2022
The Meredith Duxbury x Kiss Limited Edition Holiday line features lashes inspired by Duxbury’s glam makeup looks.
STAT+: Novel solution to biotech’s market valuation woes: Just give the cash back
STAT
NOVEMBER 2, 2022
It’s tough times to be a public biotech, especially a small one. As the market cratered over the past year and a half, hundreds of companies watched their valuations plummet to the point that, at least by stock market metrics, they’re worth less than the cash they have in the bank. Now, one biotech investor is proposing a novel solution: Just give that cash back.
UK £62 billion behind in R&D global investment share, report reveals
European Pharmaceutical Review
NOVEMBER 2, 2022
The UK’s share of global research and development ( R&D ) investment has fallen by a fifth since 2014, according to recent data analysis by the Institute for Public Policy Research (IPPR). The UK is in 11 th place in R&D investment as GDP percentage compared to other members of the Organisation for Economic Co-operation and Development (OECD), far behind international leaders, despite meeting the government’s target of 2.4 percent GDP R&D investment.
STAT+: Biotech company seeks to overcome hurdles to develop flu vaccine skin patch
STAT
NOVEMBER 2, 2022
In the future, getting a flu shot might be as easy as opening the mailbox and slapping a skin patch on your arm. Immunizations shipped to doorsteps around the globe is the dream of Michael Schrader, chief executive and cofounder of Vaxess. For more than a decade, the Cambridge, Mass., startup — whose name is a portmanteau of “vaccine” and “access” — has inched toward the creation of a vaccine that’s easy to use, doesn’t require refrigeratio
Mars adds holiday cheer to M&M’s, Dove candies
Drug Store News
NOVEMBER 2, 2022
The limited-edition launches include M&M’s Espresso Dark Chocolate and Dove Promises Silky Smooth Holiday Brownie Batter.
STAT+: Medicare punts on quality rules for new type of rural hospital
STAT
NOVEMBER 2, 2022
Hospitals that decide to convert to a new type of rural provider won’t have to report quality metrics next year, but they also won’t qualify for a popular drug discount program — a likely dealbreaker for some. That’s according to Medicare’s final rule laying out the parameters for so-called Rural Emergency Hospitals, a designation that takes effect Jan. 1, 2023 for facilities that opt in.
Gen Z utilizing social media for holiday shopping
Drug Store News
NOVEMBER 2, 2022
According to a survey by SimplicityDX, 80% of respondents plan to use social media to find holiday gifts this year, with 41% planning to use it for most or all of their holiday shopping.
New study suggests monkeypox outbreak may be fueled in part by pre-symptomatic transmission
STAT
NOVEMBER 2, 2022
A new British study suggests people who are infected with monkeypox may be able to transmit the virus to others before they develop noticeable symptoms of the disease — and that this type of transmission could account for a sizable portion of infections in the current international outbreak. Experts who reviewed the new analysis, published Wednesday in the journal BMJ, praised the rigor of the work, but warned that it cannot be considered the final answer on whether pre-symptomatic t
Align’s newest dual action probiotic caters to women’s health needs
Drug Store News
NOVEMBER 2, 2022
The Women’s Dual Action Probiotic looks to support the digestive and vaginal health of women.
CVS, Walgreens announce opioid settlements totaling $10B
STAT
NOVEMBER 2, 2022
The two largest U.S. pharmacy chains, CVS Health and Walgreen Co., announced agreements in principle Wednesday to pay about $5 billion each to settle lawsuits nationwide over the toll of opioids , and a lawyer said Walmart, a third pharmacy behemoth, is in discussions for a deal. The prospective settlements are part of a shift in the legal landscape surrounding the opioid epidemic.
Let's personalize your content